Hybridan

99 days ago

Physiomics: Round 1 to Doc Holliday but the board still need sacking and the FCA called in and here’s why

Yesterday I revealed why the ghastly snobs and poltroonish incompetents at Physiomics (PYC) faced a sack the board resolution led by Mike Whitlow, aka Doc Holliday.Today a first victory for the Doc but if the board thinks it is safe it must think again.

---

3620 days ago

Optibiotix at 79p worth (at least) 106p - Hybridan

As house broker to Optibiotix (OPTI), Hybridan is paid to be a fan and on that basis you should really take its bullishness for granted. But a note published a few days ago, before today's cracking news, explains the bull case and since we own shed loads of these shares why not give this most excellent report a wider airing. If the target was 106p pre today's good news surely it would be higher now as analyst Derren Nathan ( not a total poltroon) could cut the risk weighting on one product?

---

3722 days ago

Optibiotix - Hybridan increases its target price to 106p

Hybridan is house broker to Optibiotix (OPTI) and so although I agree with its conclusion this note is clearly biased and feel free to ignore it completely. As for Hybridan, like most brokers. its employees should be strung up with piano wire. But for what it is worth.

---

3844 days ago

Optibiotix - Hybridan ups target from 49p to 95.4p - feel free to ignore

We own these shares so feel free to ignore what we say. But for the avoidance of doubt our next top slice order is with our broker at more than 95.4p. In fact it is at more than 100p. Hybridan is house broker to Optibiotix (OPTI) so its research cannot be regarded as impartial either. It is paid by Optibiotix. But it has just published a note with a big upgrade so here you are.

---

4143 days ago

Broker Hybridan says Optiobiotix at 19.875p is worth 48.9p or 200p

Lets be upfront, RMPC owns this shares and since I often say that all brokers notes are worthless piffle I cannot make an exception here. However broker Hybridan has initiated its coverage of Optibiotix (OPTI) with a very bullish assessment indeed.

It writes:

---